跳至主要内容
临床试验/NCT00533650
NCT00533650已完成2 期

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Merck Sharp & Dohme LLC0 个研究点目标入组 227 人开始时间: 2000年12月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
227

研究概览

简要总结

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis

排除标准

  • •Person has had a previous fracture
  • •Person has rheumatoid arthritis. Person has has certain types of cancer
  • •Person has donated blood or has been in another investigational study within the last 4 weeks

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Proof of Concept (Bone Resorption/Bone Mineral... | 临床试验